University of Pennsylvania Perelman Center for Advanced Medicine — Philadelphia, Pennsylvania

University of Pennsylvania Perelman Center for Advanced Medicine is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Pennsylvania Perelman Center for Advanced Medicine has participated in 11 clinical trials with 7 currently active.

Therapeutic areas: Bilateral Sensorineural Hearing Loss, Relapsed/Refractory Peripheral T-Cell Lymphoma, Adult T Cell Leukemia/Lymphoma.

Sponsors: American Cochlear Implant Alliance, Daiichi Sankyo, vTv Therapeutics.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pennsylvania Perelman Center for Advanced Medicine?

University of Pennsylvania Perelman Center for Advanced Medicine has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pennsylvania Perelman Center for Advanced Medicine conducted?

University of Pennsylvania Perelman Center for Advanced Medicine has 11 clinical trials on record, with 7 currently active. Their work covers Bilateral Sensorineural Hearing Loss, Relapsed/Refractory Peripheral T-Cell Lymphoma, Adult T Cell Leukemia/Lymphoma.

Is University of Pennsylvania Perelman Center for Advanced Medicine accredited by Crixeo Health?

University of Pennsylvania Perelman Center for Advanced Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pennsylvania Perelman Center for Advanced Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.